Electromagnetic treatment induction apparatus and method.
Abstract
An inductive light weight device is integrated into at least one therapeutic device to be used for treatment, however, the inductive device can also be attached to the at least one therapeutic device (Step 101) Miniaturized circuitry that contains logic for a mathematical model having at least one waveform parameter used to configure at least one waveform to be coupled to a target path structure such as molecules, cells, tissues and organs, is attached to the coil by at least one cable (Step 102) . However, the connection can also be wireless.

Term
Term ended
Expired 26 April 2025, 1.4 years ago.
- Priority
- Filed
- Granted
- Expired
- Today
7 claims: 7 independent, 0 dependent
- 1CLAIMS -------- 1. A lightweight and portable inductive electromagnetic treatment device for plants, animals and humans, integrated into a surgical bandage, comprising:REIVINDICACIONES--------1. Un aparato inductivo de tratamiento electromagnético, ligero y portátil, para plantas, animales y humanos, integrado en un vendaje quirúrgico, que comprende: a miniature control circuitry (300) for configuring a waveform comprising a burst envelope of pulses that satisfies at least one of a Signal-to-Noise Ratio (SNR) model and a Ratio model Signal from Energy to Noise, on where the circuitry from control apply a wrap from density spectral high random or different towards the envelope burst rectangular or sinusoidal mono- or bi-polar pulses that induce electric fields to shape the waveform;and a lightweight flexible coil (401, 501, 601) coupled to miniature control circuitry (300) to generate at least one electromagnetic signal from the waveform and constructed from at least one electromagnetic conductor comprising a flexible conductive material to place said lightweight flexible coil to supply pulsed electromagnetic field energy, wherein said at least one electromagnetic conductor is configured to generate at least one electromagnetic signal from at least one configured waveform using a mathematical model that includes at least one waveform parameter wherein said at least una circuitería de control miniatura (300) para configurar una forma de onda que comprende una envoltura de ráfaga de impulsos que satisface al menos uno de un modelo de Proporción de Señal a Ruido (SNR) y un modelo de Proporción de Señal de Energía a Ruido, en donde la circuitería de control aplica una envoltura de densidad espectral alta aleatoria o diferente hacia la envoltura de ráfaga de impulsos mono- o bi-polares rectangulares o sinusoidales que inducen campos eléctricos para configurar la forma de onda;y un serpentín flexible ligero (401, 501, 601) acoplado a la circuitería de control miniatura (300) para generar al menos una señal electromagnética a partir de la forma de onda y construido de a partir de al menos un conductor electromagnético que comprende un material conductivo flexible para colocar dicho serpentín flexible ligero para suministrar energía de campo electromagnético pulsado, en donde dicho al menos un conductor electromagnético se configura para generar al menos una señal electromagnética a partir de al menos una forma de onda configurada utilizando un modelo matemático que incluye al menos un parámetro de forma de onda en donde dicho al menos IMPI IMPI INSTITUTO MEXICANO DE LA PROPIEDAD INDUSTRIAL a waveform parameter includes the —menus — orre — de — e “frequency component parameter that configures said at least one waveform to repeat between approximately 0.01 Hz and approximately 100 MHz according to a mathematical function, a burst amplitude envelope parameter that follows a mathematically defined amplitude function, a burst amplitude parameter that varies at each repetition according to a mathematically defined amplitude function, a peak induced electric field parameter that varies between about 1 μν / cm and about 100 mV / cm in a target path structure according to with a mathematically defined function. INSTITUTO MEXICANO DE LA PROPIEDAD INDUSTRIAL un parámetro de forma de onda incluye al—menus—orre—de—e«parámetro de componente de frecuencia que configura dicha al menos una forma de onda para repetir entre aproximadamente 0.01 Hz y aproximadamente 100 MHz de acuerdo con una función matemática, un parámetro de envoltura de amplitud de ráfaga que sigue una función de amplitud matemáticamente definida, un parámetro de amplitud de ráfaga que varía en cada repetición de acuerdo con una función de amplitud matemáticamente definida, un parámetro pico de campo eléctrico inducido que varía entre aproximadamente 1 μν/cm y aproximadamente 100 mV/cm en una estructura de trayectoria objetivo de acuerdo con una función matemáticamente definida.
- 2El aparato inductivo de tratamiento electromagnético según cualquiera de las reivindicaciones anteriores, en donde dicho aparato se incluye como parte de un soporte anatómico. two. The inductive electromagnetic treatment apparatus according to any of the preceding claims, wherein said apparatus is included as part of an anatomical support.
- 3The inductive electromagnetic treatment apparatus according to any of the preceding claims, wherein said apparatus is disposable. 3. El aparato inductivo de tratamiento electromagnético según cualquiera de las reivindicaciones anteriores, en donde dicho aparato es desechable.
- 4El aparato inductivo de tratamiento electromagnético según cualquiera de las reivindicaciones anteriores, en donde el modelo está configurado para establecer un procedimiento típico para la evaluación de SNR utiliza un solo valor de la raíz cuadrada media del voltaje de ruido (RMS). Este se calcula al tomar una raíz cuadrada de Four. The inductive electromagnetic treatment apparatus according to any of the preceding claims, wherein the model is configured to establish a typical procedure for the evaluation of SNR uses a single value of the root mean square of the noise voltage (RMS). This is calculated by taking a square root of IMPI IMPI INSTITUTO MEXICANO DE LA PROPERTY INDUSTRIAL an integration of Sn(C0) = 4kT Re [ZM(x, ar) j — srrfcrre — weddings — 4-th relevant frequencies to either fill in the membrane response or the bandwidth of a target trajectory structure. SNR can be expressed by a ratio:INSTITUTO MEXICANO DE LA PROPIEDAD INDUSTRIAL una integración de Sn(C0) = 4kT Re[ZM(x,ar)j—srrfcrre—bodas—4-a-s frecuencias relevantes para ya sea completar la respuesta de membrana o la amplitud de banda de una estructura de trayectoria objetivo. SNR puede expresarse mediante una proporción: SNR SNR RMS en donde |Vm (ω)| es la amplitud máxima de voltaje en cada frecuencia según se suministre por una forma de onda seleccionada a la estructura de trayectoria objetivo. RMS where | Vm (ω) | is the maximum amplitude of voltage at each frequency as supplied by a selected waveform to the target path structure.
- 5The inductive electromagnetic treatment apparatus according to any of the preceding claims, wherein the model is configured to assimilate that thermal noise is present in all voltage-dependent processes and represents a minimum threshold requirement to establish the appropriate SNR, the density Spectral energy, Sn (co), of thermal noise can be expressed as:5. El aparato inductivo de tratamiento electromagnético según cualquiera de las reivindicaciones anteriores, en donde el modelo está configurado para asimilar que el ruido térmico se encuentra presente en todos los procesos dependientes del voltaje y representa un requerimiento de umbral mínimo para establecer el SNR adecuado, la densidad espectral de energía, Sn(co), del ruido térmico puede expresarse como: 5 „(ω) = 4kT Re [Z¡, (x, ia)] where ΖΜ(χ, ω) is the electrical impedance of a target path structure, x is a dimension of a target path structure and Re denotes a real part of impedance of a target path structure, and Zm (x, c) is expressed What: 5„(ω) = 4kT Re[Z¡,(x,ia)] en donde ΖΜ(χ,ω) es la impedancia eléctrica de una estructura de trayectoria objetivo, x es una dimensión de una estructura de trayectoria objetivo y Re denota una parte real de impedancia de una estructura de trayectoria objetivo, y Zm(x,c) se expresa como: ΖΜ(χ, ω) = ρg +Y! + g] tanh (yx) where Re is the resistance of the extracellular fluid, Ri is the resistance of the intracellular fluid and Rg is the intermembrane resistance. ΖΜ(χ, ω) = ρg +y! + g]tanh(yx) en donde Re es la resistencia del fluido extracelular, Ri es la resistencia del fluido intracelular y Rg es la resistencia intermembrana.
- 6The inductive electromagnetic treatment apparatus according to any of the preceding claims, wherein the target path structure has an electrical impedance, and wherein the electrical impedance of the target path structure and the contributions from extracellular fluid resistance, the intracellular fluid resistance and intermembrane resistance electrically connected to the target path structure, all contribute to noise filtering in the model. 6. El aparato inductivo de tratamiento electromagnético según cualquiera de las reivindicaciones anteriores, en donde la estructura de trayectoria objetivo tiene una impedancia eléctrica, y en donde la impedancia eléctrica de la estructura de trayectoria objetivo y las contribuciones a partir de la resistencia de fluido extracelular, la resistencia del fluido intracelular y la resistencia intermembrana que se conectan eléctricamente a la estructura de trayectoria objetivo, todas contribuyen al filtrado de ruido en el modelo.
- 7The inductive electromagnetic treatment apparatus according to any of the preceding claims, for inductively coupling to tissue in plants, animals and humans, a pulse burst envelope of electromagnetic energy configured to achieve the maximum signal energy within a step of band of a biological target, wherein the waveform is detectable in a target path structure above its background activity and wherein the miniature control circuitry comprises a pulse former (305) and a pulse phase timing control (306) that 7. El aparato inductivo de tratamiento electromagnético según cualquiera de las reivindicaciones anteriores, para acoplar de manera inductiva a tejido en plantas, animales y humanos, una envoltura de ráfaga de impulso de la energía electromagnética configurado para lograr la energía de señal máxima dentro de un paso de banda de un objetivo biológico, en donde la forma de onda es detectable en una estructura de trayectoria objetivo por arriba de su actividad de fondo y en donde la circuitería de control miniatura comprende un formador de impulso (305) y un control de cronometraje de fase de impulso (306) que IMPI IMPI INSTITUTO MEXICANO DE LA PROHEDAD industrial determinan la forma de impulso, amplitud dé iáfaya1;INSTITUTO MEXICANO DE LA PROHEDAD industrial determine the form of impulse, amplitude of iáfaya1;burst wrapping and burst repetition rate. la envoltura de ráfaga y tasa de repetición de ráfaga.
Independent claims7
212 paragraphs in 51 sections, as filed
Whoever signs this title does so based on the provisions of articles β * tractions III and 7 · W $ 2 of the Industrial Property Law (Official Gazette of the Federation (O.ÓA) 06/27/1991 reported on 02 / 0871994, 10/25/1086, 12/26/1907, »06/07/1999, 01/26/2004, 06/16/2005, 01/25/2006, 05/06/2009, 01/06/2010 06/16/2010, 06/28/2010, 01/27/2012, 09 / (34/2012, 06/01/2016 and 1 »03/20181 articles 1 ·, 3rd section V subsection a), 4th and 12th sections i and III of the Regulations of the Mexican Institute of CMeSUfcÜ & Ct Industrial (DOF 14/1271999,. Amended on 07/01/2002, 07/15/2004, 07/28/2004 and 09/07/2007); Articles 1, 3 ° 4, 5 ° section V 'subsection a) 1.6 sections I and> 1tt <y; 30' of the Organic Statute of the Mexican Institute of Industrial Property (DOF 12/27/1999, amended on 10 / \ 0 / 2Ót72¿ <»W5% Jb04í¡ O4 / Oa / g00 * y 131 /)) 8/2007): 1 °. 3rd and 5th Subsection a) of the Agreement that delegates powers to the Deputy General Directors, CoonPnpppi<sup>* 1</sup>, tnrect «* ís DIvAiorretos, Tftalares, ddjs» Regional Offices, Divisional Deputy Directors, Departmental Coordinators and other subordinates of the Mepaaíj Institute ^ Industrial Property data. (DOF 12/15/1999, amended on 02/04/2000, 07/29/2004, 08/04/2004 and 09/13/2007).
This document is signed with an advanced electronic signature (FIEL), based on articles 7 BIS 2 of the Industrial Property Law; 3 of its Regulations, and 1 section III, 2 section V, 26 BIS and 26 TER of the Agreement establishing the guidelines for the use of the Payment and Electronic Services Portal (PASE) of the Mexican Institute of Industrial Property, in the procedures indicated.
DIVISIONAL PATENT DIRECTOR NAHANNY CANAL REYES
<img file="MX358779B_D0001.tif" />
Original string:
NAHANNY MARISOL CANAL REYES | OD001000000403252793 | Tax Administration Service | 1695 || MX / 201B / 76612 | MX / a / 2011/012123 | Normal patent title with PCT divisional | 1223 | GAGV | Pág (s) | MNMRo5wUafXzegzTos + RQO + l =
Digital stamp:
JqnOZF2eyP4FljGemBnNZvymTriplok5qraDDr6uHusEU + MIV7 / OwpHE + BmsehAobjBKDQHAH3pllAEvlayUGXdOD8 siThcFoj9U6c4ahY20wv¡A2 / YhcOUDDI8mW6StkqMRQGBS8EIFqU 1 KN1 FA5IK1 a4F3G3 + ylZyYo2dHp41 sKho6KVtZ YjYBnYHYUWQxzmfw46KYIn IR0UHI1VshjthLzjzauoSMEj6 + + + Jy4jKyTyPylt52 19qVxyxFA2pW0eOnsgWeU91BxO NXtn / YpZLU6LkNp + IM3Hak4el486bxdzS1OmE52Z0d69lvlMwMm1GXVhs5IG3Gj3xTLA9nNg ücu.11 == no 'j'Ví i Oio 1 PiiuMo r / anta Mana Ifipepan. Xot.riniifco. 16020
O./ift/ol ÍViUXUtO) \. '·' I
<img file="MX358779B_D0002.tif" />
MX / 2018/76612
c .. Q0O
IMPI
MEXICAN INSTITUTE OF INDUSTRIAL PROPERTY
<img file="MX358779B_D0003.tif" />
APPARATUS AND METHOD FOR THE INDUCTION OF TREATMENT__
ELECTROMAGNETIC
This application claims the benefits of provisional application US 60 / 564,887 filed on April 26, 2004. TECHNICAL FIELD
This invention relates generally to an electromagnetic treatment induction apparatus and a method for modifying behavior and using the same to achieve general cell and tissue growth, repair, maintenance by applying encoded electromagnetic information. More particularly this invention relates to the application of non-invasive surgical coupling of highly specific electromagnetic signal patterns to a variety of parts of the body. In particular, an embodiment according to the invention refers to using an induction medium such as a coil for pulsed electromagnetic supply (PEMF) for the fields to enhance the growth of living tissue and to repair in conjunction with devices such as supports, blankets, beds and wheelchairs and in conjunction with other physical therapeutic and wellness modalities, such as ultrasound, negative or positive pressure, heat, cold, massage.
BACKGROUND TECHNIQUE
It is now well established that
<img file="MX358779B_D0004.tif" />
IΜΡΙ
MEXICAN INSTITUTE
Dt THE PROPERTY
INDUSTRIAL · application of weak electromagnetic thermal fields (EMF) can result in physiologically significant in vivo and in vitro bio-effects.
EMF has been used in bone repair and bone healing applications. Waveforms comprising low-frequency, low-energy components are currently used in orthopedic clinics. The origins of using bone repair signals begin with the understanding that an electrical pathway can provide a means through which bone can respond adaptively to EMF signals. A linear physicochemical procedure employing an electrochemical model of a cell membrane predicts a range of EMF waveform patterns for which bio-effects could be expected. Since a cell membrane was probably an EMF target, it becomes necessary to find a range of waveform parameters for which an induced electric field can be electrically coupled to the cell surface, such as voltage-dependent kinetics. The extension of this linear model also involves force analysis
Lorent z.
A pulsed radio frequency (PRF) signal derived from a 27.12 MHz continuous sine wave used to heal deep tissue is known in the prior art of diathermy. A pulsed successor to the
<img file="MX358779B_D0005.tif" />
Diathermy signal was originally reported as an electromagnetic field capable of producing a non-thermal biological effect in the treatment of infections. Therapeutic PRF applications have been reported for the reduction of post-traumatic and post-operative pain and edema in soft tissues, healing of injuries, treatment of burns and nerve regeneration. The application of EMF for the resolution of traumatic edema has been used increasingly in recent years. Results to date using PRF in animal and clinical studies suggest that edema can be medically reduced from such electromagnetic stimuli.
Prior art EMF dosimetry considerations do not take into account the dielectric properties of tissue structure as opposed to the properties of isolated cells.
In recent years the clinical use of non-invasive PRF at radio frequencies comprised using pulsed bursts of a 27.12 MHz sine wave, where each pulse burst comprises an amplitude of sixty-five microseconds, having approximately 1,700 sinusoidal cycles per burst and various burst repetition rates. These limited frequency components can be coupled to relevant dielectric paths in cells and tissue.
MEXICAN INSTITUTE OF EROHEDAD
INDUSTRIAL
<img file="MX358779B_D0006.tif" />
electromagnetic
Time-varying electromagnetic fields comprise rectangular waveforms such as pulsating electromagnetic fields and sinusoidal waveforms such as pulsed radio frequency frequency fields ranging from several Hertz to a range of about 15 to about 40 MHz. , are clinically beneficial when used as an adjunct therapy for a variety of musculoskeletal injuries and conditions.
Since the 1960s, the development of modern therapeutic and prophylactic devices has been stimulated by the clinical problems associated with non-union or delayed union of bone fractures. Previous work showed that an electrical pathway can be a means through which bone responds adaptively to mechanical input. Previous therapeutic devices used implanted and semi-invasive electrodes supplying direct current (DC) to a fracture site. Non-invasive technologies were subsequently developed using
These were originally intended to provide a non-invasive, touch-free means of inducing an electrical / mechanical waveform at a cell / tissue level. The clinical applications of these technologies in orthopedics led to applications electric fields and modalities were created
IMPI
INSTITUTO MEXICANO DE LA FROI'IEDAl · INDUSTRIAL
<img file="MX358779B_D0007.tif" />
approved by world regulatory bodies for the treatment of fractures such as nonunions and fresh fractures, as well as spinal fusion. Currently several EMF devices constitute the standard therapeutic resources of orthopedic clinical practice for the treatment of difficulty to heal fractures. The success rate for these devices has been very high. The database for this indication is large enough to allow its recommended use as a safe, non-surgical, non-invasive alternative to a first bone graft. Additional clinical indications for these technologies have been reported in double-blind studies for the treatment of vascular necrosis, tendonitis, osteoarthritis, injury repair, blood circulation, and arthritis pain as well as other musculoskeletal injuries.
Cellular studies have addressed the effects of weak, low-frequency electromagnetic fields on both signal transduction pathways and growth factor synthesis. EMF can be shown to stimulate growth factor secretion after a short activator-like duration. Ion / ligand binding processes in a cell membrane are generally considered an initial EMF target path structure. The clinical relevance for treatments, for example bone repair, is the over
IMPI
INSTITUTO MEXICANO »E LA PROPERTY
INDUSTRIAL
<img file="MX358779B_D0008.tif" />
regulation, such as modulation, of growth factor production as part of the normal molecular regulation of bone repair. Cell level studies have shown the effects on calcium ion transport, cell proliferation, release of Insulin Growth Factor (IGF-II) and receptor expression.
IGF-II in osteoblasts. The effects on Factor I of
Insulin growth (IGF-I) and IGF-II have also been shown in rats to fracture callus. Stimulation of growth factor beta (TGF-β) messenger RNA (mRNA) transformation with PEMF has been demonstrated in a rat bone induction model. Studies have also demonstrated the upregulation of TGF-β mRNA by PEMF in the human osteoblast-like cell line designated MG-63, where there were increases in TGF-βΙ, collagen and osteocalcin synthesis. PEMF stimulated an increase in TGF-βΐ in both hypertrophic and atrophic cells of non-binding human tissue. Additional studies demonstrated an increase in both TGF-βΐ mRNA and protein in osteoblast cultures resulting from a direct effect of EMF on a calcium / calmodulin-dependent pathway. Cellular studies of cartilage have shown similar increases in TGF-βΙ mRNA and protein synthesis from EMF, demonstrating a therapeutic application for joint repair.
<img file="MX358779B_D0009.tif" />
<img file="MX358779B_D0010.tif" />
Several studies conclude that the upregulation '' of growth factor production may be a common denominator in the tissue-level mechanisms underlying electromagnetic stimulation.
When specific inhibitors are used, EMF can act through a calmodulin-dependent pathway. Specific PEMF and PRF signals as well as weak static magnetic fields have been previously reported to modulate Ca<sup>2+</sup> which binds CaM in a cell-free enzyme preparation. Additionally, the up-regulation of mRNA for BMP2 and BMP4 with PEMF in osteoblast cultures and the up-regulation of TGF-βΙ in bone and cartilage with PEMF has been demonstrated.
However, the prior art in this field does not use an induction apparatus that is lightweight, portable, disposable, implantable and configured, integrated or attached to at least one of the clothing, fashion accessories, footwear, bandages, anatomical supports , an anatomical blanket, clothing, pillows, mattresses, mats, wheelchairs, therapy beds, therapy chairs, health and therapeutic maintenance devices such as vacuum assisted wound closure devices, functional electrical and mechanical stimulation devices, and exercise, ultrasound, heat, cold, massage and exercise devices.
Therefore, there is a need for an apparatus
<img file="MX358779B_D0011.tif" />
induction electromagnetic treatment — and — a — method — to use the same as it is, lightweight, portable, implantable, and may be disposable. There is a further need for an electromagnetic treatment induction apparatus and method that can be used more effectively with miniaturized circuitry that optionally configures electromagnetic waveforms to inductively couple with plants, animals, and human tissue, organs, cells, and molecules to therapeutic treatment.
DESCRIPTION OF THE INVENTION
An induction apparatus for electromagnetic treatment and a method for using the same for therapeutic treatment of living tissues and cells by inductively coupled optimally configured waveforms to modify the interaction of living tissues and cells with their electromagnetic environment.
In accordance with one embodiment of the present invention, by treating a selectable body region with a flow path comprising a succession of EMF pulses having a minimum amplitude characteristic of at least about 0.01 microseconds in a pulse burst envelope that has between about 1 and about 100,000 pulses per burst, in which a voltage amplitude envelope of said pulse burst is defined by a parameter that varies
WICKED
.........--........
INSTITUTO MEXÍCAN BE LA FROFIECAD INDUSTRIAL in a random way in which the instantaneous minimum amplitude of the same is not smaller than the maximum amplitude of the same by a factor of about ten thousand. The pulse burst repetition rate can range from about 0.01 to about 10,000 Hz. A mathematically definable parameter can also be used to define an amplitude envelope of such pulse bursts.
By increasing the range of frequency components transmitted to the relevant cell pathways, access to a wide range of biophysical phenomena applicable to known healing mechanisms is advantageously achieved, including enhanced growth factor and enzyme activity and cytosine release.
According to one embodiment of the present invention by applying a random or different high spectral density envelope towards a pulse burst envelope of mono or bipolar sinusoidal or rectangular pulses that induce peak electric fields between 10 ~<sup>6</sup> and 10 volts per centimeter (V / cm), a more efficient and greater effect can be achieved in biological healing processes applicable to both soft and hard tissues in humans, animals and plants. A higher spectral density pulse burst envelope can be advantageously and efficiently coupled to dielectric paths
Μ ΡI
INSTITUTO MEXICAN · »$
OF THE PROPERTY
Physiologically relevant INDUSTMaL such as cell membrane receptors, ionic binding to cellular enzymes, and general transmembrane potential changes thus modulating angiogenesis and neovascularization.
By advantageously applying a high spectral density voltage envelope as a parameter defining modulation or pulse burst, the power requirements for such modulated pulse bursts can be significantly lower than for an unmodulated pulse. Est <
relevant cellular / molecular.
<td>I know</td><td>owes to</td><td>equalization plus</td>
<td>from</td><td>frequency</td><td>for the process</td>
<td>From</td><td>agree with</td><td>the above is</td>
<td>from</td><td>dosimetry</td><td>of transmission</td>
improved for the relevant dielectric paths and decreased power requirements.
A preferred embodiment according to the present invention utilizes a Signal to Noise Power Ratio (Energy SNR) method to configure the bioeffective waveforms and incorporates miniaturized circuitry and lightweight flexible coils. This advantageously allows a device using a power SRN procedure, minutiallized circuitry and lightweight flexible coils, to be completely portable and if desired to be constructed as disposable and if desired further to be constructed as implantable.
<img file="MX358779B_D0012.tif" />
IMPI
INSTITUTO MEXICANO DE LA FROPIEOAU INDUSTRIAL
Specifically, wide spectral density bursts of electromagnetic waveforms, configured to achieve the maximum signal energy within a bandpass of a biological target, are selectively applied to target path structures such as organs, tissues, cells and living molecules. Waveforms are selected using a single amplitude / energy comparison to that of thermal noise in a target path structure. The signals comprise bursts of at least one of the sine, rectangular, chaotic, and random waveforms, which have frequency content in the range of about 0.01 Hz to about 100 MHz at about 1 to about 100,000 bursts per second and have a rate repeat burst from about 0.01 to about 1000 bursts / second. The peak signal amplitude in a target path structure such as tissue ranges from about 1 µv / cm to about 100 mV / cm. Each signal burst envelope can be a random function that provides a means to accommodate different electromagnetic characteristics of the tissue being healed. A preferred embodiment according to the present invention comprises about 0.1 to about 100 milliseconds of pulse bursts comprising about 1 to about 200 microseconds of
<img file="MX358779B_D0013.tif" />
<img file="MX358779B_D0014.tif" />
repetition of symmetric or asymmetric pulses at about 0.1 to about 100 kilohertz within the burst. Burst envelope is a modified 1 / f function and is applied at random repetition rates between approximately 0.1 and approximately 1000 Hz. Fixed repetition rates can also be used between approximately 0.1 Hz and approximately 1000 Hz. An electric field is generated induced from about 0.001 mV / cm to about 100 mV / cm. Another embodiment according to the present invention comprises a burst of about 0.01 milliseconds to one of about 10 milliseconds of high frequency sine waves, such as 27.12 MHz, repeating at about 1 to about 100 bursts per second. An induced electric field is generated from about 0.001 mV / cm to about 100 mV / cm. The resulting waveforms can be supplied through inductive or capacitive coupling.
It is another object of the present invention to provide an electromagnetic method for the treatment of living cells and tissues comprising a broad band high spectral density electromagnetic field.
It is a further objective of the present invention to provide an electromagnetic method for the treatment of living cells and tissues that comprises the modulation of
MEXICAN INSTITUTE OF RONEDAD
INDUSTRIAL
<img file="MX358779B_D0015.tif" />
amplitude of a burst envelope - i-mpu-l-se-de-una — electromagnetic signal that will induce coupling with a maximum number of the relevant EMF-sensitive pathways in cells or tissues.
It is an objective of the present invention to configure an energy spectrum of a waveform by mathematical simulation by using signal-to-noise ratio (SNR) analysis to configure an optimized waveform to modulate angiogenesis and neovascularization, then coupling the shape. waveform configured using a generating device such as wired coils |||| ^ | that are powered by a waveform shaping device such as miniaturized electronic circuitry.
It is an object of the present invention to provide lightweight flexible coils, which can be attached to at least one of the garments, fashion accessories, footwear, bandages, anatomical supports, an anatomical blanket, clothing, pillows, mattresses, rugs, chairs. casters, therapy beds, therapy chairs, health and therapy maintenance devices such as vacuum assisted wound closure devices, electrical stimulation devices, mechanical and functional and exercise devices and bandages to deliver the optimal dose of electromagnetic treatment A, ·!
MEXICAN INSTITUTE OF INDUSTRIAL PRUPOAII
<img file="MX358779B_D0016.tif" />
non-invasive pulsed configured as shown above, 'for improved repair and growth of living tissue in animals, humans and plants.
It is another objective of the present invention, to provide multiple coils, which supply a waveform configured by the SNR / Energy analysis of a target trajectory, to increase the treatment coverage area.
It is another object of the present invention to provide multiple coils that turn on simultaneously or that turn on sequentially such as multiplexed, with the same or different waveforms optimally configured as shown above.
It is a further objective of the present invention to provide lightweight, flexible coils that focus the EMF signal to the affected tissue when incorporating the coils, supplying a waveform shaped by SNR / Energy analysis of a target trajectory in ergonomic support garments. .
It is still a further objective of the present invention to use conductive filament to create clothing for daily use and for exercise and sports that have
<td>coils</td><td>integrated,</td><td>supplying</td><td>form</td><td>from</td><td>wave</td>
<td>configured</td><td>through</td><td>the analysis</td><td>SNR / Energy</td><td>from</td><td>a</td>
<td>trajectory</td><td>objective,</td><td>standing in</td><td>proximity</td><td>with</td><td>a</td>
INSTITUTO MEXICANO, DE LA FROHEDAD INDUSTRIAL
<img file="MX358779B_D0017.tif" />
anatomical target. ___________________________________________________
It is still a further objective of the present invention to use lightweight flexible coils or conductive filaments to deliver the EMF signal to affect tissue by incorporating such conductive coils or filaments as an integral part of various types of bandages such as compression, elastic, cold packs. and hot packs and supply a waveform configured by SNR / Energy analysis of a target path.
It is another objective of the present invention to employ several coils, supplying a waveform configured by SNR / Energy analysis of a target trajectory, to increase the EMF coverage area.
It is another objective of the present invention to construct a coil, supplying a waveform configured by SNR / Energy analysis of a target trajectory, using conductive filament.
It is another objective of the present invention to construct a coil, supplying a waveform shaped by SNR / Energy analysis of a target path, using thin flexible conductive wire.
It is another objective of the present invention to supply the same or different waveforms configured by SNR / Energy analysis of a
ί.7k x I
MEXICAN INSTITUTE OF INDUSTRIAL PROPERTY
<img file="MX358779B_D0018.tif" />
target trajectory, simultaneous or secneTrciarlmerrte — a — cm — only or multiple coils.
It is still a further objective of the present invention to incorporate at least one coil into a surgical wound dressing to apply an enhanced EMF signal non-invasively and non-surgically to the surgical wound dressing to be used in combination with standard wound treatment.
It is another objective of the present invention to construct the coils that supply a waveform configured by SNR / Energy analysis of a target trajectory, for easy attachment and separation to bandages, garments and supports when using attachment means such as sailboat, an adhesive and any other such temporary attachment means.
Another objective of the present invention, coils that deliver a waveform by SNR / Energy analysis of a target, which are integrated with beds, therapy chairs and wheelchairs.
Another objective of the present invention, coils that deliver a waveform by SNR / Energy analysis of a target, that integrate with various surfaces such as pressure release, inflatable bed,
Is to provide configured therapeutic path
Is to provide configured therapy path,
- 17 IMPI
INSTITUTO MEXICAN! ' OF THE INDUSTRIAL moriEPAD
<img file="MX358779B_D0019.tif" />
fluid, visco-elastic and fluidized air and other support surfaces.
It is another object of the present invention to provide coils that deliver a waveform shaped by SNR / Energy analysis of a target trajectory, which are integrated with therapeutic seat cushions such as foamed, fluidized or inflexible cushions.
It is another objective of the present invention, to provide coils that deliver a waveform configured by SNR / Energy analysis of a target trajectory, that are integrated with at least one of the therapeutic mattress covers, sheets, blankets, pillows, pillow covers and therapeutic devices that can apply fixed or intermittent pressure such as vented vests.
It is another objective of the present invention to provide the inclusion of a flow path in any therapeutic surface, structure or device to improve the effectiveness of such therapeutic surfaces, structures or devices by supplying a waveform shaped by SNR / Energy analysis of a target trajectory.
It is another objective of the present invention to incorporate the coils that supply a waveform
<img file="MX358779B_D0020.tif" />
INSTITUTO MEXICANO CE LA PROPERTY
INDUSTRIAL
<img file="MX358779B_D0021.tif" />
configured by SNR / Energy analysis of a target trajectory, in footwear such as shoes.
It is another objective of the present invention to integrate at least one coil that supplies a waveform configured by SNR / Energy analysis of a target trajectory, with a surface, structure or therapeutic device to improve the effectiveness of such surface, structure or therapeutic device. .
The foregoing and still other objects and advantages of the present invention will become apparent from the Brief Description of the Drawings set forth hereinafter, Detailed Description of the Invention, and Claims appended herein.
Brief Description of Drawings
The preferred embodiments of the present invention
<td>will be described below accompanying drawings:</td><td>in more</td><td colspan="3">detail, with reference</td><td>to the</td>
<td>Figure 1</td><td>it's a</td><td>diagram of</td><td>f lu jo</td><td>of a</td><td>method</td>
<td>to use a</td><td>apparatus</td><td>inductive</td><td>in order to</td><td colspan="2">treatment</td>
electromagnetic according to one embodiment of the present invention;
Figure 2 is a view of the control circuitry in accordance with a preferred embodiment of the present invention;
Figure 3 is a block diagram of
IMPI
MEXICAN INSTITUTE OF INDUSTRIAL FRONEDAD
<img file="MX358779B_D0022.tif" />
miniaturized circuitry according to the preferred method of the present invention;
Figure 4 depicts an inductive electromagnetic treatment apparatus integrated into a hip, thigh and lower back support garment, in accordance with a preferred embodiment of the present invention;
Figure 5 depicts an inductive electromagnetic treatment apparatus integrated into a head and face support garment in accordance with a preferred embodiment of the present invention;
Figure 6 depicts an inductive electromagnetic treatment apparatus integrated into a surgical bandage on a human forearm in accordance with a preferred embodiment of the present invention;
Figure 7 depicts an inductive electromagnetic treatment apparatus integrated into a mattress pad in accordance with a preferred embodiment of the present invention;
Figure 8A depicts an inductive electromagnetic treatment apparatus integrated into a sock in accordance with a preferred embodiment of the present invention;
Figure 8B depicts an inductive electromagnetic treatment apparatus integrated into a shoe in accordance with a preferred embodiment of the present invention;
Figure 9 represents an inductive apparatus for industrial
<img file="MX358779B_D0023.tif" />
electromagnetic treatment integrated into a therapeutic caffTa in accordance with a preferred embodiment of the present invention; Y
Figure 10 depicts an inductive electromagnetic treatment apparatus integrated into a chest garment in accordance with a preferred embodiment of the present invention.
MODES TO CARRY OUT THE INVENTION
The time-varying induced currents from PEMF or PRF devices flow in a target path structure such as a molecule, cell, tissue and organ and it is these currents that are a stimulus to which cells and tissues can react in a physiologically significant form. The electrical properties of a target path structure affect the levels and distributions of the induced current. Molecules, cells, tissues and organs are all in an induced current path such as cells in a gap junction contact. Ion or ligand interactions at binding sites in macromolecules that can reside on a membrane surface are voltage-dependent, i.e., electrochemical, processes that can respond to an induced electromagnetic field (E). The induced current reaches these sites through a surrounding ionic medium. The presence of cells in a
MEXICAN INSTITUTE OF PROFIF.DAD
INDUSTRIAL
<img file="MX358779B_D0024.tif" />
current trajectory causes a current 'ihdücTcfa' to deteriorate more rapidly with time (J (t)). This is due to an added electrical impedance of cells from membrane capacitance and bonding time constants and other voltage-sensitive membrane processes such as membrane transport.
Equivalent electrical circuit models have been derived representing various charged and membrane interface configurations. For example, in binding to Calcium (Ca<sup>2+</sup>), the change in the concentration of Ca binding<sup>2+</sup> at a binding site due to induced E can be described in a frequency domain by an impedance expression such as:
icúCt which is in the form of a series of resistance-capacitance equivalent electrical circuit. Where ω is an angular frequency defined as 2πί, where f is the frequency, i = -1 * 2, Zb (ro) is the junction impedance and Ri<sub>OR</sub>n and Cion are equivalent bonding resistance and capacitance of an ion bonding path. The value of the equivalent binding time constant, Ti<sub>On</sub> = RionCion, is related to an ion-binding rate constant, kb through Ti<sub>On</sub> = RionCion = 1 / kb. Thus, the time constant characteristic of this trajectory is determined by the binding kinetics to
<img file="MX358779B_D0025.tif" />
<img file="MX358779B_D0026.tif" />
ion. ------ E induced from a PEMF or PRF signal can cause current to flow into an ion binding path and affect the number of Ca ion binding<sup>2+</sup> per unit time. An electrical equivalent of this is a change in voltage across the equivalent junction capacitance Ci<sub>On</sub>, which is a direct measurement of the change in electric charge stored by Ci<sub>OR</sub>n. The electric charge is directly proportional to a surface concentration of the Ca ions<sup>2+</sup> at the binding site, that is, the storage of charge is equivalent to the storage of ions or other charged species on cell surfaces and junctions. Electrical impedance measurements, as well as direct kinetic analysis of junction rate constants, provide values for the time constants necessary for shaping a PMF waveform to match a bandpass of the target path structures. This allows a required range of frequencies for any given induced E waveform for optimal coupling to the target impedance, such as bandpass.
Ion binding to regulatory molecules is a common EMF target, for example Ca binding<sup>2+</sup> to calmodulin (CaM). The use of this trajectory is based on the acceleration of wound repair, for example the
IMPI
INSTITUTJ MEXICANO L> E LA PfcOHEDAÍ; INDUSTRIAL
<img file="MX358779B_D0027.tif" />
bone repair, which involves 1-a — modulation — of · —growth factors released in various stages of repair. Growth factors such as platelet-derived growth factor (PDGF), fibroblast growth factor (FGF), and an epidermal growth factor (EGF) are all involved in an appropriate stage of healing. Angiogenesis and neovascularization are also integral to wound repair and can be modulated by PMF. All these factors are dependent on Ca / CaM.
Using a Ca / CaM path a waveform can be configured for which the induced energy is sufficiently above the background thermal noise energy. Under correct physiological conditions, this waveform can have a physiologically significant bio-effect.
The application of an SNR model of Energy for Ca / CaM requires the knowledge of electrical equivalents of binding kinetics to Ca<sup>+2</sup> in Cam. Within the first order binding kinetics, changes in the concentration of Ca binding<sup>2+</sup> at CaM binding sites over time can be characterized in a frequency domain by an equivalent binding time constant, Ti<sub>on</sub> = RionCion where Ri<sub>On</sub> And ci<sub>on</sub> are the equivalent bonding resistance and capacitance of the ion bonding path. Τ ±<sub>Ο</sub>η se
IMPI
MEXICAN INSTITUTE DF. INDUSTRIAL PROHEDAP relates to an ion-binding rate constant, k<sub>b</sub> through you<sub>on</sub> = RionCion = 1 / kb. The published values for kb can then be used in a cell array model to assess SNR by comparing the voltage induced by a PRF signal to thermal fluctuations in voltage at a CaM binding site. Using the numerical values for the PMF answer, such as V<sub>ma</sub>x = 6.5xl0<sup>-7</sup> sec<sup>-1</sup>, [Ca<sup>2+</sup>] = 2.5 μΜ, Kd = 30 μιη, [Ca<sup>2+</sup>CaM] = Kd ([Ca<sup>2+</sup>] + [CaM]), produces kb = 665 sec<sup>-1</sup> (Tion = 1.5 msec). Such a value for Tion can be used in an electrical equivalent circuit for ion binding whereas SNR energy analysis can be carried out for any waveform structure.
According to one embodiment of the present invention, a mathematical model can be configured to assimilate that thermal noise is present in all voltage-dependent processes and represents a minimum threshold requirement to establish the appropriate SNR. The spectral energy density, S<sub>n</sub> (ω), of thermal noise can be expressed as:
Sn (G>) = 4kT Re [Zm (x, ω)] where Zm (x, o>) is the electrical impedance of a target path structure, x is a dimension of a target path structure and Re denotes a real part of impedance of a target path structure. Ζ<sub>Μ</sub>(χ, ω) can be expressed as:
IMPI
Ζ<sub>Μ</sub>(χ, ω)
<img file="MX358779B_D0028.tif" />
And so (γχ)
MEXICAN PROPERTY INSTITUTE
INDUSTRIAL
<img file="MX358779B_D0029.tif" />
This equation clearly shows that the electrical impedance of the target path structure and the contributions from extracellular fluid resistance (R<sub>and</sub>), intracellular fluid resistance (Ri) and intermembrane resistance (R<sub>g</sub>) that are electrically connected to a target path structure, all contribute to noise filtering.
A typical procedure for the evaluation of SNR uses a single value of the root mean square of the noise voltage (RMS). This is calculated by taking a square root of an integration of
Sa ((o) = 4kT Re [Z<sub>M</sub>(x, co)] over all relevant frequencies to either complete the membrane response or the bandwidth of a target path structure. SNR can be expressed by a ratio:
SNR
<img file="MX358779B_D0030.tif" />
RMS where | Vm (ω) | is the maximum amplitude of voltage at each frequency as supplied by a selected waveform to the target path structure.
One embodiment in accordance with the present invention comprises a pulse burst envelope having a
IMPI
INSTITUTO MEXICAN ·> OF INDUSTRIAL PROPERTY
<img file="MX358779B_D0031.tif" />
high spectral density, so that the effect of therapy on relevant dielectric pathways such as cell membrane receptors, ion binding to cellular enzymes and general transmembrane potential changes is enhanced. Accordingly, by increasing a number of frequency components transmitted to the relevant cellular trajectories, a wide range of biophysical phenomena is accessible, such as growth factor modulation and cytokine release and ion binding in regulatory molecules, applicable to mechanisms. known curatives. According to one embodiment of the present invention, applying a random or different high spectral density envelope to a burst envelope of rectangular or sinusoidal mono- or bi-polar pulsed pulses that induce peak electric fields between approximately 10 ~<sup>6</sup> and approximately 100 V / cm, it produces a greater effect in the biological healing processes applicable to both soft and hard tissues.
In accordance with yet another embodiment of the present invention, when applying a high spectral density voltage envelope as a modulation or pulse burst defining a parameter, the power requirements for such amplitude modulated pulse bursts can be significantly lower than that. of an unmodulated pulse burst containing pulses within a range
<img file="MX358779B_D0032.tif" />
<img file="MX358779B_D0033.tif" />
of similar frequency. This is due to a substantial reduction in duty cycle within repetitive burst trains caused by the imposition of an irregular and preferably random amplitude on what may otherwise be a substantially uniform pulse burst envelope. Accordingly, the dual advantages of improved transmitted dosimetry at the relevant dielectric paths and decreased energy requirement are achieved.
Referring to Figure 1, where Figure 1 is a flow chart of a method of using an inductive apparatus to deliver electromagnetic signals to target path structures such as plant, animal and human molecules, cells, tissues and organs to therapeutic and prophylactic purposes according to one embodiment of the present invention. A lightweight inductive device is integrated into at least one therapeutic device to be used for treatment, however the inductive device can also be attached to at least one therapeutic device (Step 101). Miniaturized circuitry containing logic for a mathematical model that has at least one waveform parameter used to configure at least one waveform to match a target path structure such as molecules, cells, tissues, and organs, is attached to the coil using at least one wire í Μ ΡI
INSTITUTE ΜEXJCANO ¥ ¡> ¿«£ ^ 0 Jj D £ LA PROHEDAD V> -<sub>B</sub>.Zr<sup>,</sup>lS INDUSTRIAL (Stage 102). However, the connection can also be wireless. The configured waveform satisfies an Energy SNR or SNR model so that for a given and known target path structure it is possible to select at least one waveform parameter so that a waveform is detectable in the path structure. target above its background activity (Step 103) such as baseline thermal fluctuations in voltage and electrical impedance in a target path structure dependent on the state of the cell and the tissue, that is to say if the state is at least one of rest, growth, replacement and that responds to damage.
A preferred embodiment of a generated electromagnetic signal is comprised of a burst of arbitrary waveforms having at least one waveform parameter that includes a plurality of frequency components ranging from about 0.01 Hz to about 100 MHz where the plurality of frequency components satisfy an Energy SNR model (Step 104). A repetitive electromagnetic signal can be generated for example inductively, from said at least one configured waveform (Step 105). The repeating electromagnetic signal can also be generated conductively. The electromagnetic signal is coupled to a target path structure such as molecules,
- 29 IMPI
MEXICAN INSTITUTE OF INDUSTRIAL PROPERTY
<img file="MX358779B_D0034.tif" />
cells, tissues and organs through the ·· 'output — of the — inductive apparatus integrated into the support (Step 106).
Figure 2 illustrates a preferred embodiment of an apparatus in accordance with the present invention. A miniature control circuit 201 is coupled to one end of at least one connector 202 such as a cable. The opposite end of the at least one connector is coupled to a generating device such as a pair of electrical coils 203. The generation device is built to have electrical properties that optimize the generation of the electromagnetic signals coming from the waveforms configured to satisfy at least one of an SNR model, an Energy SNR model and any other mathematical model used for the configuration of the waveform. The miniature control circuit 201 is constructed in a way that applies a mathematical model that is used to configure the waveforms. The configured waveforms have to satisfy an Energy SNR or SNR model so that for a given and known target path structure, it is possible to select waveform parameters that satisfy Energy SNR or SNR so that a waveform it is detectable in the target track structure above its background activity. A preferred embodiment according to the present invention applies a mathematical model to induce a magnetic field
<img file="MX358779B_D0035.tif" />
time variation and a time-va-ri-ac-iom field in a target path structure such as molecules, cells, tissues and organs comprising about 10 to about 100 msec of bursts of about 1 to about 100 microseconds of repetition of rectangular pulses at approximately 0.1 to approximately 10 pulses per second. The peak amplitude of the induced electric field is between approximately 1 uV / cm and approximately 100 mV / cm, varying according to a modified 1 / f function where f = frequency. A waveform configured using a preferred embodiment in accordance with the present invention can be applied to a target path structure such as molecules, cells, tissues and organs for a preferred total exposure time of below 1 minute to 240 minutes per day. However, other exposure times can be used. The waveforms configured by the miniature control circuit 201 are directed to a generation device 203 such as electrical coils through the connector 202. The generation device 203 supplies a pulsating magnetic field configured according to a mathematical model, which can used to treat a target pathway structure such as a heart in a thorax 204. The miniature control circuit applies a pulsating magnetic field across a
<img file="MX358779B_D0036.tif" />
<img file="MX358779B_D0037.tif" />
prescribed time and can be repeated automatically · —Ta application of the pulsating magnetic field for as many applications as needed in a given period of time, for example 10 times a day. A preferred embodiment in accordance with the present invention can be positioned to treat the heart in a chest 204 via a delivery device. Coupling a pulsing magnetic field to an angiogenesis and neovascularization target pathway structure such as ions and ligands, therapeutically and prophylactically reduces inflammation thereby reducing pain and promoting healing. When the electric coils are used as the generating device 203, the electric coils can be energized with a time-varying magnetic field that induces a time-varying magnetic field in a target path structure in accordance with Earaday's law. An electromagnetic signal generated by generating device 203 can also be applied using electromagnetic coupling, where the electrodes are in direct contact with the skin or other electrically conductive boundary of a target path structure. In yet another embodiment in accordance with the present invention, the electromagnetic signal generated by the generating device 203 can also be applied using electromagnetic coupling where there is a
<img file="MX358779B_D0038.tif" />
<img file="MX358779B_D0039.tif" />
air gap between a 2ΤΓ3 FaT generation device such as an electrode and a target path structure such as molecules, cells, tissues, and organs. An advantage of the preferred modality in accordance with the present invention is that its lightweight miniaturized circuitry and coils allow it to be used with physical therapy treatment modalities and at any location in the body for which pain relief and healing are desired. An advantageous result of applying the preferred embodiment according to the present invention is that the angiogenesis and neovascularization of the living organism can be maintained and improved.
Figure 3 depicts a block diagram of a preferred embodiment in accordance with the present invention of a miniature control circuit 300. The miniature control circuit 300 produces waveforms that drive a generating device such as cable coils described above in Figure 2. The miniature control circuit can be activated by any actuation means such as an on / off switch. The miniature control circuit 300 has a power source such as a lithium battery 301. A preferred embodiment of the power source has an output voltage of 3.3V but other voltages can be used. In another embodiment according to the present invention the energy source may be a
IMPI
MEXICAN INSTITUTE OF PROPERTY
INDUSTRIAL
<img file="MX358779B_D0040.tif" />
external power source such as an electrical current outlet such as an AC / DC outlet, coupled with the present invention for example by means of a plug and cable. A switching power supply 302 controls the voltage for a micro-controller 303. A preferred embodiment of the micro-controller 303 uses a 4MHz 8-bit micro-controller 303 but other combination MHz-bit micro-controllers may be used. Switching power supply 302 also supplies current to storage capacitors 304. A preferred embodiment of the present invention uses storage capacitors that have a 220uF output but other outputs can be used. Storage capacitors 304 allow high frequency pulses to be supplied to a coupling device such as inductors (Not Shown). The micro-controller 303 also controls a pulse former 305 and a pulse phase timing control 306. The pulse former 305 and pulse phase timing control 306 determine the pulse shape, burst amplitude, pulse shape. burst wrapping and burst repetition rate. An integral waveform generator, such as a sine wave or arbitrary number generator can also be incorporated to provide specific waveforms. A voltage level conversion sub-circuit 308 controls an induced field
<img file="MX358779B_D0041.tif" />
supplied towards a structure of LiayucLuii'd ubjeLivo ·. A Hexfet switch 308 allows random amplitude pulses to be supplied to the output 309 which directs a waveform to at least one coupling device such as an inductor. Microcontroller 303 can also control the total exposure time of a single treatment of a target pathway structure such as a molecule, cell, tissue, and organ. The miniature control circuit 300 can be constructed to apply a pulsating magnetic field for a prescribed time and to automatically repeat the application of the pulsating magnetic field for as many applications as needed in a given period of time, for example 10 times a day. A preferred embodiment according to the present invention uses treatment times of about 10 minutes to about 30 minutes.
Referring to Figure 4 there is illustrated an embodiment in accordance with the present invention of an inductive apparatus for electromagnetic treatment integrated into the posterior support garment 100 for the hip, thigh and lower back. Several lightweight flexible coils 401 are integrated into the supporting garment. Lightweight flexible coils can be constructed from thin flexible conductive wire, conductive filament, and any other flexible conductive material. Flexible coils connect to
IMPI
MEXICAN INSTITUTE OF INDUSTRIAL PROPERTY
<img file="MX358779B_D0042.tif" />
at least one end of at least one r.ah 1.a_4Q2 --— however the flexible coils can also be configured to connect directly to circuitry 403 or wirelessly. Light miniaturized circuitry 403 that configures waveforms in accordance with one embodiment of the present invention is attached to at least one different end of said at least one wire. When activated, the light miniaturized circuitry 403 configures the waveforms that are directed to the flexible coils (401) to create PEMF signals that are coupled to a target path structure.
Referring to FIG. 5 an embodiment in accordance with the present invention of an inductive apparatus for integrated electromagnetic treatment is illustrated in a head and face support garment 500. Several lightweight flexible coils 501 are integrated into the support garment. Lightweight flexible coils can be constructed from thin flexible conductive wire, conductive filament, and any other flexible conductive material. Flexible coils connect to at least one end of at least one cable 502. However, flexible coils can also be configured to connect directly to circuitry 503 or wirelessly. The light miniaturized circuitry 503 that configures the waveforms, in accordance with one embodiment of the present invention, is attached to at least one different end
<img file="MX358779B_D0043.tif" />
<img file="MX358779B_D0044.tif" />
of said at least one cable. When “atrrtva — Ta — C aό'ΠiTSΓTa light miniaturized 503 it configures the waveforms that are directed to the flexible coils 501) to create PEMF signals that are coupled to a target path structure.
Referring to Figure 6 there is illustrated an embodiment in accordance with the present invention of an inductive electromagnetic treatment apparatus integrated into a surgical bandage applied to a human forearm 600. Several lightweight flexible coils 601 are integrated into the bandage. Lightweight flexible coils are constructed of thin flexible conductive wire, conductive filament, and any other flexible conductive material. The flexible coils connect to at least one end of at least one cable 602.
However, flexible coils can also be configured to connect directly to circuitry.
603 or wirelessly. Light miniaturized circuitry 603 that configures the waveforms in accordance with one embodiment of the present invention, is attached to at least one different end of said at least one wire. When activated, the light miniaturized circuitry 603 configures the waveforms that are directed to the flexible coils (601) to create PEMF signals that are coupled to a target path structure.
Referring to Figure 7 an embodiment according to the present invention of an inductive apparatus is illustrated
IMPI
INSTITI -TÚ MEXICAN '..' OF INDUSTRIAL PROPERTY
<img file="MX358779B_D0045.tif" />
integrated electromagnetic treatment ~ en'un ~ padding for mattress 700. Several lightweight flexible coils 701 are integrated into the padding for mattress. Lightweight flexible coils can be constructed from thin flexible conductive wire, conductive filament, and any other flexible conductive material. The flexible coils connect to at least one end of at least one cable 702. However, the flexible coils can also be configured to connect directly to circuitry 703 or wirelessly. Light miniaturized circuitry 703 that configures the waveforms in accordance with one embodiment of the present invention is attached to at least one different end of said at least one wire.
When activated, the light miniaturized circuitry 703 configures the waveforms that are directed to the flexible coils (701) to create PEMF signals that are coupled to a target path structure.
Referring to Figures 8A and 8B there is illustrated an embodiment in accordance with the present invention of an inductive electromagnetic treatment apparatus integrated into a sock 801 and a shoe 802. Several lightweight flexible coils 803 are integrated into the bandage. Lightweight flexible coils can be constructed from thin flexible conductive wire, conductive filament, and any other flexible conductive material. Flexible coils
IMPI
MEXICAN INSTITUTE OF INDUSTRIAL PROPERTY
<img file="MX358779B_D0046.tif" />
connect to at least one end of at least one wire 804. However, flexible coils can also be configured to connect directly to circuitry
805 or wirelessly. The lightweight miniaturized circuitry 805 that configures the waveforms in accordance with one embodiment of the present invention, is attached to at least one different end of said at least one wire. When activated the light miniaturized circuitry 805 configures the waveforms that are directed to the flexible coils (806) to create PEMF signals that are coupled to a target path structure.
Referring to Figure 9 there is illustrated an embodiment in accordance with the present invention of an inductive electromagnetic treatment apparatus integrated into a therapy bed 900. Several lightweight flexible coils 901 are integrated into the bed. Lightweight flexible coils can be constructed from thin flexible conductive wire, conductive filament, and any other flexible conductive material. The flexible coils connect to at least one end of at least one cable 902. However, the flexible coils can also be configured to connect directly to circuitry 903 or wirelessly. The lightweight miniaturized circuitry 903 that configures the waveforms in accordance with one embodiment of the present invention, is attached to at least one different end as "
IMPI
MEXICAN INSTITUTE OF INDUSTRIAL PROPERTY
<img file="MX358779B_D0047.tif" />
of said at least one cable. When activated, the lightweight miniaturized ultrasound 903 configures the waveforms that are directed to the flexible coils (901) to create PEMF signals that are coupled to a target path structure.
Referring to Figure 10 there is illustrated an embodiment in accordance with the present invention of an inductive electromagnetic treatment apparatus integrated into a chest garment 1000, such as a bra. Several 1001 lightweight flexible coils fit into one bra. Lightweight flexible coils can be constructed from thin flexible conductive wire, conductive filament, and any other flexible conductive material. Flexible coils connect to at least one end of at least one cable 1002. However, flexible coils can also be configured to connect directly to circuitry 1003 or wirelessly. Light miniaturized circuitry 1003 that configures waveforms in accordance with one embodiment of the present invention is attached to at least one different end of said at least one wire. When activated, the light miniaturized circuitry 1003 configures the waveforms that are directed to the flexible coils (1001) to create PEMF signals that are coupled to a target path structure.
Having described the modalities for an inductive electromagnetic treatment apparatus and a method for
IMPI
MEXICAN INSTITUTE OF INDUSTRIAL PROPERTY
<img file="MX358779B_D0048.tif" />
Using the same, it should be noted that modifications and variations can be made by persons skilled in the art in light of the above teachings. It should therefore be understood that changes may be made to the particular embodiments of the invention described which are within the scope and spirit of the invention as defined by the appended claims.
Contents51
59 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5 Sheet 6 Sheet 7 Sheet 8 Sheet 9 Sheet 10 Sheet 11 Sheet 12 Sheet 13 Sheet 14 Sheet 15 Sheet 16 Sheet 17 Sheet 18 Sheet 19 Sheet 20 Sheet 21 Sheet 22 Sheet 23 Sheet 24 Sheet 25 Sheet 26 Sheet 27 Sheet 28 Sheet 29 Sheet 30 Sheet 31 Sheet 32 Sheet 33 Sheet 34 Sheet 35 Sheet 36 Sheet 37 Sheet 38 Sheet 39 Sheet 40 Sheet 41 Sheet 42 Sheet 43 Sheet 44 Sheet 45 Sheet 46 Sheet 47 Sheet 48 Sheet 49 Sheet 50 Sheet 51 Sheet 52 Sheet 53 Sheet 54 Sheet 55 Sheet 56 Sheet 57 Sheet 58 Sheet 59
146 members in 15 offices
Priority claims14
| Document | Office | Kind | Date |
|---|---|---|---|
| 56488704 | United States of America | P | |
| 56488704 | United States of America | P | |
| 60564887 | United States of America | – | |
| 11114666 | United States of America | – | |
| 11466605 | United States of America | A | |
| 11466605 | United States of America | A | |
| 2005014234 | United States of America | W | |
| 2005014234 | United States of America | W | |
| 11114666 | – | – | – |
| 60564887 | – | – | – |
| PCTUS2005014234 | – | – | – |
| US20040564887P | – | – | – |
| US20050114666 | – | – | – |
| WO2005US14234 | – | – | – |
Members146
| Document | Office | Kind | |
|---|---|---|---|
| AU2004296198A1 | Australia | A1 | |
| CA2548270A1 | Canada | A1 | |
| WO2005056111A2 | World Intellectual Property Organization (WIPO) | A2 | |
| US2005197522A1 | United States of America | A1 | |
| AU2005234749A1 | Australia | A1 | |
| CA2563660A1 | Canada | A1 | |
| WO2005102188A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2005237539A1 | Australia | A1 | |
| CA2564795A1 | Canada | A1 | |
| US2005251229A1 | United States of America | A1 | |
| WO2005056111A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO2005105013A2 | World Intellectual Property Organization (WIPO) | A2 | |
| US2005288744A1 | United States of America | A1 | |
| EP1694409A2 | European Patent Office (EPO) | A2 | |
| AU2006220660A1 | Australia | A1 | |
| CA2601114A1 | Canada | A1 | |
| WO2006096698A2 | World Intellectual Property Organization (WIPO) | A2 | |
| US2006212077A1 | United States of America | A1 | |
| EP1740107A1 | European Patent Office (EPO) | A1 | |
| CN1901967A | China | A | |
| US2007026514A1 | United States of America | A1 | |
| KR20070024533A | Republic of Korea | A | |
| BRPI0417129A | Brazil | A | |
| EP1758539A2 | European Patent Office (EPO) | A2 | |
| AU2005336126A1 | Australia | A1 | |
| CA2622143A1 | Canada | A1 | |
| US2007060981A1 | United States of America | A1 | |
| WO2007030122A2 | World Intellectual Property Organization (WIPO) | A2 | |
| KR20070038038A | Republic of Korea | A | |
| AU2006299945A1 | Australia | A1 | |
| CA2600201A1 | Canada | A1 | |
| WO2007044059A2 | World Intellectual Property Organization (WIPO) | A2 | |
| MXPA06012077A | Mexico | A | |
| ZA200605544B | South Africa | B | |
| MXPA06012389A | Mexico | A | |
| WO2007044059A9 | World Intellectual Property Organization (WIPO) | A9 | |
| CN1980610A | China | A | |
| US2007173904A1 | United States of America | A1 | |
| AU2007208304A1 | Australia | A1 | |
| CA2640134A1 | Canada | A1 | |
| WO2007044059A8 | World Intellectual Property Organization (WIPO) | A8 | |
| WO2007087322A2 | World Intellectual Property Organization (WIPO) | A2 | |
| JP2007524476A | Japan | A | |
| BRPI0509432A | Brazil | A | |
| BRPI0509444A | Brazil | A | |
| WO2005105013A3 | World Intellectual Property Organization (WIPO) | A3 | |
| JP2007532284A | Japan | A | |
| JP2007535978A | Japan | A | |
| WO2007044059A3 | World Intellectual Property Organization (WIPO) | A3 | |
| KR20070119024A | Republic of Korea | A | |
| WO2007146342A2 | World Intellectual Property Organization (WIPO) | A2 | |
| EP1868591A2 | European Patent Office (EPO) | A2 | |
| ZA200609524B | South Africa | B | |
| KR20080003799A | Republic of Korea | A | |
| EP1877128A2 | European Patent Office (EPO) | A2 | |
| TW200803948A | Taiwan Province of China | A | |
| WO2007087322A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO2007146342A9 | World Intellectual Property Organization (WIPO) | A9 | |
| US2008058793A1 | United States of America | A1 | |
| AR059180A1 | Argentina | A1 | |
| MX2007010974A | Mexico | A | |
| WO2008036383A1 | World Intellectual Property Organization (WIPO) | A1 | |
| NZ551316A | New Zealand | A | |
| CN101160152A | China | A | |
| WO2008051521A2 | World Intellectual Property Organization (WIPO) | A2 | |
| US2008132971A1 | United States of America | A1 | |
| US2008140155A1 | United States of America | A1 | |
| NZ548283A | New Zealand | A | |
| EP1937356A2 | European Patent Office (EPO) | A2 | |
| WO2008051521A3 | World Intellectual Property Organization (WIPO) | A3 | |
| ZA200708478B | South Africa | B | |
| JP2008531239A | Japan | A | |
| KR20080080483A | Republic of Korea | A | |
| EP1877128A4 | European Patent Office (EPO) | A4 | |
| EP1976591A2 | European Patent Office (EPO) | A2 | |
| JP2008538513A | Japan | A | |
| EP1758539A4 | European Patent Office (EPO) | A4 | |
| WO2007146342A3 | World Intellectual Property Organization (WIPO) | A3 | |
| MX2008009629A | Mexico | A | |
| KR20090023544A | Republic of Korea | A | |
| WO2006096698A3 | World Intellectual Property Organization (WIPO) | A3 | |
| CN101415462A | China | A | |
| WO2007030122A3 | World Intellectual Property Organization (WIPO) | A3 | |
| CN101432041A | China | A | |
| BRPI0520604A2 | Brazil | A2 | |
| CN101443074A | China | A | |
| EP2066393A1 | European Patent Office (EPO) | A1 | |
| JP2009524480A | Japan | A | |
| EP2077789A2 | European Patent Office (EPO) | A2 | |
| JP2009528073A | Japan | A | |
| CN101505676A | China | A | |
| BRPI0607959A2 | Brazil | A2 | |
| BRPI0607963A2 | Brazil | A2 | |
| EP1937356A4 | European Patent Office (EPO) | A4 | |
| EP1976591A4 | European Patent Office (EPO) | A4 | |
| CN1980610B | China | B | |
| US7740574B2 | United States of America | B2 | |
| US7744524B2 | United States of America | B2 | |
| US2010179373A1 | United States of America | A1 | |
| US7758490B2 | United States of America | B2 |
Numbers
- Publication
- 358779
- Publication, DOCDB
- 358779
- Publication, EPODOC
- MX358779
- Application
- 2011012123
- Application, DOCDB
- 2011012123
- Application, EPODOC
- MX20110012123
Titles2
- Spanish
- APARATO Y MÉTODO PARA LA INDUCCIÓN DE TRATAMIENTO ELECTROMAGNÉTICO.
- English
- APPARATUS AND METHOD FOR THE INDUCTION OF ELECTROMAGNETIC TREATMENT.
Classification
- CPC, 11
- A61H39/002
- A61N2/00
- A61H2201/10
- A61N1/326
- A61N1/40
- A61N2/004
- A61N2/008
- A61N2/02
- A61H33/00
- A61N1/32
- A61N1/44
- IPC, 5
- A61N1 40
- A61H33 00
- A61H39 00
- A61N2 00
- A61N2 02